Efficiency Integrated Chemotherapy With EGFR Receptor Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer and an Activating EGFR Gene Mutation. Вопр. онкол. 2022, 67 (2), 246-253. https://doi.org/10.37469/0507-3758-2021-67-2-246-253.